article_metadata: Kok Hoe Chan Tung Shu Majd Al Shaarani Putao Cen
article_metadata: 10.1177/23247096241257333
article_metadata: J Investig Med High Impact Case Rep
article_metadata: 2024 Jan-Dec:12:23247096241257333.
article_metadata: enfortumab vedotin neoadjuvant pembrolizumab upper tract urothelial carcinoma
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38804541/
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Carcinoma, Transitional Cell / drug therapy Carcinoma, Transitional Cell / pathology
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Carcinoma, Transitional Cell / drug therapy Carcinoma, Transitional Cell / pathology Case Reports Aged, 80 and over Antibodies, Monoclonal / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Female Humans Kidney Neoplasms / drug therapy Kidney Neoplasms / pathology Kidney Pelvis / pathology Neoadjuvant Therapy Nephroureterectomy Antibodies, Monoclonal, Humanized pembrolizumab enfortumab vedotin Antibodies, Monoclonal Antineoplastic Agents, Immunological
article_metadata: PMC11135087
article_metadata: 38804541
article_metadata: Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract
article_metadata: 2024